Crossref journal-article
Informa UK Limited
Future Medicinal Chemistry (301)
Bibliography

Peach, M. L., Zakharov, A. V., Liu, R., Pugliese, A., Tawa, G., Wallqvist, A., & Nicklaus, M. C. (2012). Computational Tools And Resources For Metabolism-Related Property Predictions. 1. Overview Of Publicly Available (Free And Commercial) Databases And Software. Future Medicinal Chemistry, 4(15), 1907–1932.

Authors 7
  1. Megan L Peach (first)
  2. Alexey V Zakharov (additional)
  3. Ruifeng Liu (additional)
  4. Angelo Pugliese (additional)
  5. Gregory Tawa (additional)
  6. Anders Wallqvist (additional)
  7. Marc C Nicklaus (additional)
References 181 Referenced 52
  1. Markey SP . Pathways of drug metabolism. In: Principles of Clinical Pharmacology. Atkinson AJ Jr Daniels CE Dedrick RL Grudzinskas CV Markey SP (Eds). Academic Press San Diego CA USA (2001).
  2. 10.2174/156802611794480927
  3. 10.1001/jama.1990.03450210088038
  4. Alfaro CL PiscitelliSC. Drug interactions. In: Principles of Clinical Pharmacology. Atkinson AJ Jr Daniels CE Dedrick RL Grudzinskas CV Markey SP (Eds). Academic Press San Diego UK (2001).
  5. O‘Reilly B . Drug pirates make good. Fortune Magazine 10 December 1998.
  6. 10.1016/0092-8674(95)90340-2
  7. 10.1073/pnas.210244497
  8. 10.1016/S1359-6446(97)01087-8
  9. 10.1016/S1359-6446(97)01096-9
  10. 10.1016/1359-6446(96)10017-9
  11. 10.1016/S0169-409X(02)00011-X
  12. 10.1038/nrd1032
  13. 10.1517/17425250802568009
  14. 10.1517/17425255.2011.553599
  15. 10.1021/ci200542m
  16. 10.4155/fmc.12.152
  17. Testa B , JennerP. The coming of age of drug metabolism: a citation classic commentary.Curr. Contents Life Sci.33, 16 (1990). / Curr. Contents Life Sci. / The coming of age of drug metabolism: a citation classic commentary. by Testa B (1990)
  18. Testa B JennerP. Drug Metabolism: Chemical and Biochemical Aspects. Dekker NY USA (1976).
  19. 10.1517/17425255.2.4.545
  20. 10.1080/00498250500354402
  21. 10.1124/dmd.111.039982
  22. 10.2174/138620711796957170
  23. Erhardt P . Drug metabolism data: past and present status.Med. Chem. Res.8(7–8), 400–421 (1998). / Med. Chem. Res. / Drug metabolism data: past and present status. by Erhardt P (1998)
  24. Hawkins DR . Biotransformations: A Survey of the Biotransformations of Drugs and Chemicals in Animals. Hawkins DR (Ed.). Royal Society of Chemistry Cambridge UK (1988–1996).
  25. Roberts TR HutsonDH JewessPJ. Metabolic Pathways of Agrochemicals. Royal Society of Chemistry Cambridge UK (1998–1999).
  26. Pfeifer S GildemeisterB PöhlmannH BorchertHH. Biotransformation von Arzneimitteln. Verlag Chemie Weinheim Germany (1977–1983).
  27. Pfeifer S . Pharmacokinetics. VEB Verlag Volk und Gesundheit Berlin Germany (1986–1990).
  28. 10.1021/ci034078l
  29. 10.1517/17425255.1.2.303
  30. 10.1016/0263-7855(88)85004-5
  31. 10.1021/ja00336a004
  32. 10.1021/ci00022a014
  33. 10.1021/ci00022a015
  34. 10.1021/ci9601123
  35. 10.1080/10629369908039182
  36. 10.1021/ci0202739
  37. 10.1021/ja00175a040
  38. 10.1124/dmd.30.1.7
  39. 10.1021/jm050529c
  40. 10.2174/1381612043452596
  41. 10.1080/10915810591000631
  42. 10.1021/jm0613471
  43. 10.1002/cmdc.200800384
  44. 10.1021/ml100016x
  45. 10.1021/ml200246f
  46. 10.1021/ci300009z
  47. 10.1021/ci3001524
  48. 10.1021/ci2000488
  49. 10.1080/03602530701836662
  50. 10.1002/cbdv.200900078
  51. 10.1080/10629360903568671
  52. 10.1186/1471-2105-8-59
  53. 10.1186/1471-2105-11-362
  54. 10.1021/ci600376q
  55. 10.1023/A:1020881520931
  56. 10.1021/ct200462q
  57. 10.1021/jm050540c
  58. 10.1358/dnp.2003.16.7.829354
  59. 10.1007/s11095-006-0277-7
  60. 10.1007/BF02977789
  61. 10.2174/138620711795508377
  62. 10.1038/nrd1851
  63. 10.1517/14740338.3.4.379
  64. 10.3109/03602539709037591
  65. 10.1081/DMR-120001392
  66. 10.1093/nar/gkr1132
  67. 10.1093/nar/gkn580
  68. 10.1093/nar/gkq813
  69. Filimonov D PoroikovV. Probabilistic approaches in activity prediction. In: Chemoinformatics Approaches to Virtual Screening. Varnek A Tropsha A (Eds). Royal Society of Chemistry Cambridge UK (2008). (10.1039/9781847558879-00182)
  70. 10.1021/ci000383k
  71. 10.1021/ci030283p
  72. 10.1016/S0169-7439(01)00181-2
  73. 10.2165/00003088-199732030-00004
  74. 10.1080/10629360412331319871
  75. 10.1021/ci700010t
  76. Anderson C . A deeper metabolism model. Drug Discovery News 14 November 2007.
  77. 10.1007/s10822-010-9381-1
  78. 10.14573/altex.2009.3.167
  79. 10.1002/cmdc.201000358
  80. 10.1002/cmdc.200500024
  81. 10.1111/j.1742-7843.2006.pto_471.x
  82. 10.1016/j.toxlet.2007.06.011
  83. 10.1002/minf.200900064
  84. 10.1021/jm701122q
  85. Atkinson AJ Jr. Clinical pharmacokinetics. In: Principles of Clinical Pharmacology. Atkinson. AJ Jr Daniels CE Dedrick RL Grudzinskas CV Markey SP (Eds). Academic Press San Diego CA USA (2001).
  86. 10.2165/00003088-200342060-00002
  87. 10.2174/138920010794233503
  88. Baranczewski P , StańczakA, SundbergKet al. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 58(4), 453–472 (2006). / Pharmacol. Rep. / Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. by Baranczewski P (2006)
  89. Krejsa CM , HorvathD, RogalskiSLet al. Predicting ADME properties and side effects: the BioPrint approach. Curr. Opin. Drug Discov. Devel. 6(4), 470–480 (2003). / Curr. Opin. Drug Discov. Devel. / Predicting ADME properties and side effects: the BioPrint approach. by Krejsa CM (2003)
  90. Olah M RadR OstopoviciLet al. WOMBAT and WOMBAT-PK: bioactivity databases for lead and drug discovery. In: Chemical Biology: from Small Molecules to Systems Biology and Drug Design. Schreiber SL Kapoor TM Wess G (Eds). Wiley-VCH Wenheim Germany (2007). (10.1002/9783527619375.ch13b)
  91. 10.1093/nar/gkq1126
  92. Hardman JG LimbirdLE GilmanAG. Goodman and Gilman’s The Pharmacological Basis of Therapeutics (10th Edition). McGraw-Hill NY USA (2001).
  93. 10.1093/nar/gkr777
  94. 10.1124/dmd.108.020479
  95. 10.1023/B:JCAM.0000021861.31978.da
  96. 10.1016/S0163-7258(96)00140-4
  97. 10.1016/j.drudis.2012.01.017
  98. 10.1021/ci2003126
  99. 10.1016/S1359-6446(99)01401-4
  100. 10.1080/15376510701857320
  101. 10.1124/dmd.110.034918
  102. 10.1007/s10822-005-9014-2
  103. 10.1007/s10822-005-9026-y
  104. 10.1023/A:1025358319677
  105. 10.2174/156802606778108915
  106. 10.1038/nbt.2176
  107. 10.1021/ci060117s
  108. 10.1007/978-1-60761-839-3_3
  109. Flockhart DA . Clinical pharmacogenetics. In: Principles of Clinical Pharmacology. Atkinson AJ Jr Daniels CE Dedrick RL Grudzinskas CV Markey SP (Eds). Academic Press San Diego CA USA (2001).
  110. Accelrys. Metabolite. http://accelrys.com/products/databases/bioactivity/metabolite.html
  111. Accelrys. Metabolism. http://web.archive.org/web/20011215121925/www.accelrys.com/chem_db/metabolism.html
  112. GeneGo. MetaBase. www.genego.com/metabase.php
  113. GeneGo. MetaDrug. www.genego.com/metadrug.php
  114. CompuDrug. MetabolExpert. www.compudrug.com/?q=node/36
  115. CompuDrug. Source of metabolic reactions. www.compudrug.com/sites/default/files/filepicker/1/source_of_metabolic_reactions.pdf
  116. MultiCASE. META. www.multicase.com/products/prod05.htm
  117. Lhasa Limited. General information about Meteor. www.lhasalimited.org/index.php/meteor
  118. Optibrium. StarDrop. www.optibrium.com/stardrop
  119. Optibrium. FAQs: P450 models. www.optibrium.com/community/faq/p450-models
  120. Simulations Plus. ADMET Predictor. www.simulations-plus.com/Products.aspx?grpID=1&cID=11&pID=13
  121. Simulations Plus. Structure-to-property prediction. www.simulations-plus.com/Products.aspx?pID=13&mlID=14&lmID=85
  122. Simulations Plus. Metabolism product module. www.simulations-plus.com/Products.aspx?pID=13&mID=15
  123. Molecular Discovery. MetaSite. www.moldiscovery.com/soft_metasite.php
  124. Laboratory of Mathematical Chemistry. TIMES. http://oasis-lmc.org/?section=software&swid=4
  125. ChemAxon. Metabolizer preview. www.chemaxon.com/products/metabolizer-preview
  126. Fujitsu Kyushu Systems. ADME database. http://jp.fujitsu.com/group/kyushu/en/services/admedatabase
  127. FQS Poland. ADME database. www.fqs.pl/chemistry_materials_life_science/products/adme_db
  128. CAChe Research. Chemical and physical property prediction from electronic properties of molecular surfaces. http://cacheresearch.com/cepos.html
  129. Chemical Computing Group. Molecular Operating Environment. www.chemcomp.com/software.htm
  130. Accelrys. Pipeline Pilot Overview. http://accelrys.com/products/pipeline-pilot
  131. University of Copenhagen. SMARTCyp Web Service. www.farma.ku.dk/smartcyp
  132. Rensselaer Exploratory Center for Cheminformatics Research. RS-WebPredictor. http://reccr.chem.rpi.edu/Software/RS-WebPredictor
  133. ACD/Labs. ACD/Percepta. www.acdlabs.com/products/percepta
  134. ACD/Labs. ACD/ADME suite. http://web.archive.org/web/20090622115310/www.acdlabs.com/products/admet/adme
  135. ACD/Labs. P450 regioselectivity. www.acdlabs.com/download/app/admet/1006_p450regioselectivity.pdf
  136. ACD/Labs. Cytochrome P450 Specificity Module. www.acdlabs.com/download/docs/datasheets/datasheet_cyps.pdf
  137. University of Cambridge. MetaPrint2D. www-metaprint2d.ch.cam.ac.uk
  138. Sourceforge. MetaPrint2D. http://sourceforge.net/projects/metaprint2d
  139. Bioclipse Wiki. MetaPrint2D. http://wiki.bioclipse.net/index.php?title=MetaPrint2D
  140. Schrödinger. Prediction of cytochrome P450 sites of metabolism using induced fit docking. https://docs.google.com/file/d/0B-qRWhJqQzmbYmU2YzI5YWEtYjEy00ZmFlLTgwMjAtOTQ5NzA2ODI2ZDYz/edit?hl=en&authkey=CMGttaEK
  141. Fujitsu. BioFrontier/P450: major functions. http://web.archive.org/web/20070813232709/www.fqs.pl/life_science/biofrontier/functions
  142. National Center for Biotechnology Information. The PubChem Project. http://pubchem.ncbi.nlm.nih.gov
  143. National Center for Biotechnology Information. PubChem BioAssay database; AID 410. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=410
  144. National Center for Biotechnology Information. PubChem BioAssay database; AID 884. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=884
  145. National Center for Biotechnology Information. PubChem BioAssay database; AID 883. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=883
  146. National Center for Biotechnology Information. PubChem BioAssay database; AID 899. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=899
  147. National Center for Biotechnology Information. PubChem BioAssay database; AID 891. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=891
  148. National Center for Biotechnology Information. PubChem BioAssay database; AID 1851. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1851
  149. National Center for Biotechnology Information. PubChem BioAssay database; AID 777. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=777
  150. National Center for Biotechnology Information. PubChem BioAssay database; AID 778. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=778
  151. National Center for Biotechnology Information. PubChem BioAssay database; AID 2804. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=2804
  152. National Center for Biotechnology Information. PubChem BioAssay database; AID 885. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=885
  153. National Center for Biotechnology Information. PubChem BioAssay database; AID 10.4 http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1024
  154. National Center for Biotechnology Information. PubChem BioAssay database; AID 10.5 http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1025
  155. Mount Desert Island Biological Lab. Comparative Toxicogenomics database. http://ctdbase.org
  156. GeneXplain. PASS. www.genexplain.com/pass
  157. Optibrium. FAQs: ADME QSAR models. www.optibrium.com/community/faq/adme-qsar-models
  158. Evaluate Pharma. Accelrys announces release of software for prediction ADME in early drug discovery. www.evaluatepharma.com/Universal/View.aspx?type=Story&id=20793
  159. Accelrys. Discovery studio. http://accelrys.com/products/discovery-studio
  160. Accelrys. ADMET descriptors in discovery studio. http://accelrys.com/products/datasheets/admet-descriptors.pdf
  161. Accelrys. ADME-Tox component collection. http://accelrys.com/products/pipeline-pilot/component-collections/adme-tox.html
  162. FQS Poland. ADMEWORKS predictor models. http://www.fqs.pl/chemistry_materials_life_science/products/admeworks_predictor/models
  163. Molecular Networks. isoCYP – Predictions of the predominant isoform of human cytochrome P450 substrates. www.molecular-networks.com/products/isocyp
  164. Biograf 3R. VirtualToxLab. www.biograf.ch/index.php?id=projects&subid=virtualtoxlab
  165. US FDA. Drugs@FDA. www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
  166. Cerep. BioPrint profile and services. www.cerep.fr/cerep/users/pages/ProductsServices/bioprintservices.asp
  167. Sunset Molecular. WOMBAT-PK. www.sunsetmolecular.com/index.php?option=com_content&view=article&id=16&Itemid=11
  168. Wishart D. DrugBank. www.drugbank.ca
  169. Aureus Sciences. ADME overview. www.aureus-sciences.com/aureus/web/guest/adme-overview
  170. Aureus Sciences. AurPASS. www.aureus-sciences.com/aureus/web/guest/aurpass-overview
  171. Evolvus. Microsomal stability database. www.evolvus.com/Products/Databases/MicrosomalStability.html
  172. Strand Life Sciences. QSAR World. www.qsarworld.com/qsar-datasets.php?mm=5
  173. EBI. ChEMBL database. www.ebi.ac.uk/chembl
  174. National Center for Biotechnology Information. PubChem BioAssay database; AID 1940. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1940
  175. National Center for Biotechnology Information. PubChem BioAssay Database; AID 1555. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1555
  176. CompuDrug. MEXAlert. www.compudrug.com/?q=node/37
  177. Schrödinger. QikProp. www.schrodinger.com/products/14/17
  178. Sourceforge. Chemistry development kit. http://cdk.sf.net
  179. Hothorn T. CRAN task view: machine learning and statistical learning. http://cran.r-project.org/web/views/MachineLearning.html
  180. KNIME. www.knime.org
  181. Molecular Libraries Program. Center capabilities. https://mli.nih.gov/mli/mlpcn/mlpcn-probe-production-centers
Dates
Type When
Created 12 years, 10 months ago (Oct. 22, 2012, 12:54 p.m.)
Deposited 1 year, 3 months ago (May 23, 2024, 3:50 p.m.)
Indexed 2 months ago (July 4, 2025, 10:03 a.m.)
Issued 12 years, 11 months ago (Oct. 1, 2012)
Published 12 years, 11 months ago (Oct. 1, 2012)
Published Online 12 years, 10 months ago (Oct. 22, 2012)
Published Print 12 years, 11 months ago (Oct. 1, 2012)
Funders 1
  1. Intramural Research Program of NIH
    Awards1
    1. HHSN261200800001E

@article{Peach_2012, title={Computational Tools And Resources For Metabolism-Related Property Predictions. 1. Overview Of Publicly Available (Free And Commercial) Databases And Software}, volume={4}, ISSN={1756-8927}, url={http://dx.doi.org/10.4155/fmc.12.150}, DOI={10.4155/fmc.12.150}, number={15}, journal={Future Medicinal Chemistry}, publisher={Informa UK Limited}, author={Peach, Megan L and Zakharov, Alexey V and Liu, Ruifeng and Pugliese, Angelo and Tawa, Gregory and Wallqvist, Anders and Nicklaus, Marc C}, year={2012}, month=oct, pages={1907–1932} }